BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37923598)

  • 1. Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity.
    Calzadilla N; Zilberstein N; Hanscom M; Al Rashdan HT; Chacra W; Gill RK; Alrefai WA
    Dig Liver Dis; 2024 Jun; 56(6):923-931. PubMed ID: 37923598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's in Metabolomics for Alcoholic Liver Disease?
    Suciu AM; Crisan DA; Procopet BD; Radu CI; Socaciu C; Tantau MV; Stefanescu HO; Grigorescu M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):51-58. PubMed ID: 29557415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
    Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism.
    Xu R; He L; Vatsalya V; Ma X; Kim S; Mueller EG; Feng W; McClain CJ; Zhang X
    Am J Physiol Gastrointest Liver Physiol; 2023 Feb; 324(2):G142-G154. PubMed ID: 36513601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.
    Medici V; Peerson JM; Stabler SP; French SW; Gregory JF; Virata MC; Albanese A; Bowlus CL; Devaraj S; Panacek EA; Rahim N; Richards JR; Rossaro L; Halsted CH
    J Hepatol; 2010 Sep; 53(3):551-7. PubMed ID: 20561703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease.
    Mrdjen M; Huang E; Pathak V; Bellar A; Welch N; Dasarathy J; Streem D; McClain CJ; Mitchell M; Radaeva S; Barton B; Szabo G; Dasarathy S; Wang Z; Hazen SL; Brown JM; Nagy LE
    Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37820283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.
    Zhang G; Chen H; Ren W; Huang J
    Scand J Clin Lab Invest; 2023 Feb; 83(1):8-17. PubMed ID: 36484775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered urinary tryptophan metabolites in alcohol-associated liver disease.
    Xu R; Vatsalya V; He L; Ma X; Feng W; McClain CJ; Zhang X
    Alcohol Clin Exp Res (Hoboken); 2023 Sep; 47(9):1665-1676. PubMed ID: 37431708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and significance of autoantibodies in patients with alcoholic liver disease.
    Lian M; Hua J; Sheng L; Qiu DK
    J Dig Dis; 2013 Jul; 14(7):396-401. PubMed ID: 23517444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota, a key player in alcoholic liver disease.
    Cassard AM; Ciocan D
    Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma.
    Ohhira M; Ohtake T; Saito H; Ikuta K; Tanaka K; Tanabe H; Kawashima T; Fujimoto Y; Naraki T; Ono M; Kohgo Y
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):67S-70S. PubMed ID: 10235282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
    Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes.
    Apostolov R; Wong D; Low E; Vaz K; Spurio J; Worland T; Liu D; Chan RK; Gow P; Grossmann M; Sinclair M
    Scand J Gastroenterol; 2023; 58(11):1328-1334. PubMed ID: 37282344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function.
    Lucey MR; Connor JT; Boyer TD; Henderson JM; Rikkers LF;
    Am J Gastroenterol; 2008 Jul; 103(7):1698-706. PubMed ID: 18494835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.